Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Ornithine

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,159Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arcturus Updates OTC Deficiency And Cystic Fibrosis Programs
    Arcturus Updates OTC Deficiency And Cystic Fibrosis Programs

    01 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240701483874/en

    BUSINESSWIRE
    01 Jul 2024
    Share Share
    iECURE Gets FDA Fast Track For OTC Deficiency Therapy
    iECURE Gets FDA Fast Track For OTC Deficiency Therapy

    07 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240507362839/en

    BUSINESSWIRE
    07 May 2024
    Share Share
    Enforcement Report - Week of November 17, 2021
    Enforcement Report - Week of November 17, 2021

    17 Nov 2021

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-17-2021-1637135168.pdf

    FDA
    17 Nov 2021
    Share Share
    Arcturus Announces First Healthy Volunteer Dosed in Phase 1 Study of ARCT-810
    Arcturus Announces First Healthy Volunteer Dosed in Phase 1 Study of ARCT-810

    05 Jun 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/06/05/2044275/0/en/Arcturus-Therapeutics-Announces-First-Healthy-Volunteer-Dosed-in-Phase-1-Study-of-ARCT-810-for-Ornithine-Transcarbamylase-OTC-Deficiency.html

    GLOBENEWSWIRE
    05 Jun 2020
    Share Share
    Mallinckrodt begins enrolment in Phase IIa study for liver cirrhosis
    Mallinckrodt begins enrolment in Phase IIa study for liver cirrhosis

    13 Aug 2019

    // DRUGDEVELOPMENT

    https://www.drugdevelopment-technology.com/news/mallinckrodt-iia-liver-cirrhosis-study/

    DRUGDEVELOPMENT
    13 Aug 2019
    Share Share